• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Microbiome Times

Editor's Choice

Poor gut health connected to severe COVID-19, new review shows

January 18, 2021 Microbiome Times

People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems. However, autopsy and other studies have also revealed that the infection can affect […]

Finance

Vedanta Biosciences Announces $25 Million Investment from Pfizer Inc.

January 13, 2021 Microbiome Times

Vedanta Biosciences, a leading clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human microbiome-derived bacteria, today announced that Pfizer Inc. (NYSE: PFE) has made a $25 […]

Pharma & Human Health

Landmark human study is first to reveal strong links between specific gut microbes, diet and health, including weight

January 12, 2021 Microbiome Times

Diets rich in certain plant-based foods are linked with the presence of gut microbes that are associated with a lower risk of developing conditions such as obesity, type 2 diabetes and cardiovascular disease, according to […]

Finance

Eligo inks deal with GSK potentially worth up to $224M

January 12, 2021 Microbiome Times

Eligo Bioscience SA (Eligo) today announced that it has entered into a research and option agreement with GlaxoSmithKline (NYSE: GSK) aimed at advancing Eligobiotics® for the treatment or prevention of acne vulgaris with a pioneering […]

Pharma & Human Health

The incredible, variable bacteria living in your mouth

January 8, 2021 Microbiome Times

Bacteria often show very strong biogeography – some bacteria are abundant in specific locations while absent from others – leading to major questions when applying microbiology to therapeutics or probiotics: how did the bacteria get […]

Animal Health

Nanoplastics alter intestinal microbiome and threaten human health

January 5, 2021 Microbiome Times

We live in a world invaded by plastic. Its role as a chemically stable, versatile and multi-purpose fostered its massive use, which has finally translated into our current situation of planetary pollution. Moreover, when plastic […]

Pharma & Human Health

Stressing the Small Stuff: Cork Researchers Unravel how the Microbiome may hold the Secret to how Stress Affects the Body

December 17, 2020 Microbiome Times

It’s not stress that kills us; it is our reaction to it” are the famous words of the Hungarian physiologist Hans Selye. Indeed understanding how stress affects the body is an important endeavour in understanding […]

Pharma & Human Health

Microbes in dental plaque look more like relatives in soil than those on the tongue

December 16, 2020 Microbiome Times

From the perspective of A. Murat Eren, PhD, the mouth is the perfect place to study microbial communities. “Not only is it the beginning of the GI tract, but it’s also a very special and […]

Pharma & Human Health

MSK study is the first to link microbiota to dynamics of the human immune system

December 11, 2020 Microbiome Times

In recent years, the microbiota — the community of bacteria and other microorganisms that live on and in the human body — has captured the attention of scientists and the public, in part because it’s […]

Pharma & Human Health

The Regents of the University of California and Evolve BioSystems Win Court Order, Denying Abbott’s attempt to Dismiss Patent Infringement Suit

December 8, 2020 Microbiome Times

The Regents of the University of California and Evolve BioSystems are pleased to announce that an Illinois federal judge has recently denied a motion by Abbott Laboratories to dismiss a patent infringement suit jointly filed […]

Pharma & Human Health

Leading immune-focused microbiome drug company taps Biose Industrie for manufacturing expertise

November 27, 2020 Microbiome Times

Every microbiome-focused company has its own approach for discovering drug candidates—but rarely is the mechanism of action for a live biotherapeutic product (LBP) known from the outset. Microbiome pharma company ImmunoBiome, however, uses a unique […]

Posts navigation

« 1 … 35 36 37 … 78 »

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter